Research has shown [64] that NKG2D expression is significantly increased in the livers of NASH patients, the expression of NKG2D ligands such as MICA and MICB is also markedly increased in the liver of NASH patients [65]. This evidence concerns the gene MICB and metabolic dysfunction-associated steatohepatitis.